🇺🇸 Morphine Patient Controlled Analgesia in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Secondary Adrenocortical Insufficiency — 1 report (100%)
Other Pain Management approved in United States
Frequently asked questions
Is Morphine Patient Controlled Analgesia approved in United States?
Morphine Patient Controlled Analgesia does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Morphine Patient Controlled Analgesia in United States?
Istituti Ospitalieri di Cremona is the originator. The local marketing authorisation holder may differ — check the official source linked above.